tradingkey.logo

iSpecimen Inc

ISPC
0.330USD
-0.015-4.38%
Close 02/06, 16:00ETQuotes delayed by 15 min
3.22MMarket Cap
LossP/E TTM

iSpecimen Inc

0.330
-0.015-4.38%

More Details of iSpecimen Inc Company

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

iSpecimen Inc Info

Ticker SymbolISPC
Company nameiSpecimen Inc
IPO dateJun 17, 2021
CEOField (Katharyn)
Number of employees24
Security typeOrdinary Share
Fiscal year-endJun 17
Address8 Cabot Road
CityWOBURN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code08101
Phone17813016700
Websitehttps://www.ispecimen.com/
Ticker SymbolISPC
IPO dateJun 17, 2021
CEOField (Katharyn)

Company Executives of iSpecimen Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Specimens – contracts with customers
95.82K
89.89%
Shipping and other
10.78K
10.11%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Specimens – contracts with customers
95.82K
89.89%
Shipping and other
10.78K
10.11%

Shareholding Stats

Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
Other
96.62%
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
Other
96.62%
Shareholder Types
Shareholders
Proportion
Hedge Fund
1.59%
Research Firm
0.86%
Investment Advisor
0.70%
Corporation
0.43%
Investment Advisor/Hedge Fund
0.43%
Individual Investor
0.26%
Other
95.73%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
27
349.56K
3.58%
+223.90K
2025Q3
26
96.86K
1.75%
-11.14K
2025Q2
31
133.51K
3.29%
-45.19K
2025Q1
37
201.48K
8.20%
-43.25K
2024Q4
37
175.36K
18.22%
-42.87K
2024Q3
38
178.54K
25.34%
-4.65K
2024Q2
37
155.60K
21.84%
-23.10K
2024Q1
38
168.39K
35.92%
-17.71K
2023Q4
42
174.70K
38.71%
-30.54K
2023Q3
48
208.00K
46.18%
-25.86K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Renaissance Technologies LLC
153.46K
1.53%
+153.46K
--
Sep 30, 2025
Virtu Americas LLC
63.26K
0.63%
+63.26K
--
Sep 30, 2025
OBF Investments LLC
42.10K
0.42%
+1.00
+0.00%
Dec 31, 2024
Geode Capital Management, L.L.C.
41.69K
0.42%
+26.88K
+181.52%
Sep 30, 2025
Scientech Research LLC
29.49K
0.29%
+29.49K
--
Sep 30, 2025
The Vanguard Group, Inc.
29.41K
0.29%
+28.17K
+2277.28%
Sep 30, 2025
Wolf (James G)
25.25K
0.25%
-14.29K
-36.14%
Jun 03, 2024
Jane Street Capital, L.L.C.
20.26K
0.2%
+20.26K
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.83K
0.03%
--
--
Sep 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Date
Ex-dividend Date
Type
Ratio
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
KeyAI